Conflict of interest statement: M.A.L. is an advisory board member for Eli Lilly and Pfizer Inc., consultant to Novartis, and receives support from Pfizer for research not overlapping with the work reported here. M.R.H. has received research support, not used in the current studies, from investigator-initiated sponsored proposals from Eli Lilly & Co. and Boehringer-Ingelheim.